A sturgeon-derived bioactive compound beneficially modulates nuclear receptors controlling metabolic functions in patients with metabolic syndrome. uri icon

authors

  • Marotta, Francesco
  • Srivastava, Nalini
  • Milazzo, Michele
  • Italia, Angelo
  • Lorenzetti, Aldo
  • Catanzaro, Roberto
  • Zerbinati, Nicola
  • Jain, Shalini
  • Solimene, Umberto
  • Yaduvanshi, Santos K
  • Hariom Yadav, PhD
  • Sapienza, Chiara

publication date

  • January 1, 2013